Emerald Innovations
Emerald Innovations is a touchless sensor and machine learning platform that provides in-depth health analytics through passive in-home monitoring, used extensively in clinical trials and health applications.
Company Overview
Emerald Innovations is a touchless sensor and machine learning platform specializing in health analytics. The company provides technology that passively monitors users at home, recording and sending data without requiring user interaction. Emerald Innovations is headquartered in Cambridge, MA, and was founded by MIT faculty and researchers. The company is bootstrapped, cashflow positive, and 100% employee-owned.
Health Monitoring Platform
Emerald Innovations' platform uses advanced machine learning and signal processing algorithms to detect movements and generate detailed data regarding mobility, gait, and patterns such as respiration and sleep quality. The technology allows for in-depth monitoring of health metrics in real-world settings without additional burdens on patients or trial sites. The device operates passively, continuously analyzing movements and behaviors and uploading data to the Emerald Cloud via an encrypted connection.
Applications in Clinical Trials
Emerald Innovations' technology has been employed by some of the world's largest pharmaceutical companies in various clinical trials, including Phase 2 and Phase 4 trials. It provides patient-centric clinical endpoints and real-world evidence reflecting patients' quality of life. The platform delivers objective data on sleep patterns, stress levels, and other metrics to understand better how they impact the efficacy and safety of trial treatments.
Technological Capabilities
Emerald Innovations' platform can determine individuals' positions and monitor their activity levels. Using wireless signals, it can extract breathing signals and sleep stages, discerning between deep sleep and dreaming. Recent research also indicates that the platform can generate a 3D skeleton using these wireless signals. This technology provides comprehensive insights into a person's health through continuous, passive monitoring.
Customer and Market Impact
Emerald Innovations serves major pharmaceutical companies and has secured repeated contracts, attesting to its technology's reliability and effectiveness. The platform is applied across various health monitoring applications, including COVID-19 monitoring, sleep and musculoskeletal disorders, and pulmonary and neurological diseases. The company's solutions offer better data capture and advanced insights, leading to more effective clinical trials and improved patient outcomes.